UCLA research could lead to a simple saliva test capable of diagnosing — at an early stage — diabetes and cancer, and perhaps neurological disorders and autoimmune diseases.
The study, the most comprehensive analysis ever conducted of RNA molecules in human saliva, reveals that saliva contains many of the same disease-revealing molecules that are contained in blood. It was published online today by the peer-reviewed journal Clinical Chemistry and will be published in the journal’s January 2015 special print issue, “Molecular Diagnostics: A Revolution in Progress.”
“If we can define the boundaries of molecular targets in saliva, then we can ask what the constituents in saliva are that can mark someone who has pre-diabetes or the early stages of oral cancer or pancreatic cancer — and we can utilize this knowledge for personalized medicine,” said Dr. David Wong, a senior author of the research and UCLA’s Felix and Mildred Yip Endowed Professor in Dentistry.
Wong said the test also holds promise for diagnosing Type 2 diabetes, gastric cancer and other diseases. “If you don’t look in saliva, you may miss important indicators of disease,” Wong said. “There seems to be treasure in saliva, which will surprise people.”
RNA, widely known as a cellular messenger that makes proteins and carries out DNA’s instructions to other parts of the cell, is now understood to perform sophisticated chemical reactions and is believed to perform an extraordinary number of other functions, at least some of which are unknown.
Wong’s research over the past decade has focused on identifying biomarkers in saliva. His laboratory discovered that some of the same RNA that is inside human cells are also present in saliva and can be used to detect diseases — a surprising finding, he said, because enzymes in saliva can degrade RNA, making the mouth “a hostile environment.”
The new research is a collaboration with Xinshu (Grace) Xiao, the paper’s other senior author and a UCLA associate professor of integrative biology and physiology in the UCLA College. Using state-of-the-science genomics and bioinformatics, the researchers analyzed 165 million genetic sequences.
Among the many forms of RNA are some unusual ones that live in the mouth and in cells. For example, it wasn’t known until very recently that RNA comes in a circular form; the linear form has long been known. But the UCLA scientists identified more than 400 circular RNAs in human saliva — the first discovery of circular RNA in saliva or any body fluid — including 327 forms that were previously unknown.
Circular RNA’s function in saliva is not entirely understood, although it does serve as a sponge for tiny RNA molecules called microRNAs, which bind to it.
“Circular RNAs in saliva may be protecting other RNAs,” said Xiao, who also is a member of UCLA’s Molecular Biology Institute. It’s likely, she said, that circular RNAs in saliva protect microRNAs from being degraded.
MicroRNAs, which once seemed to be little more than molecular noise, play important roles in many cell types, and have been implicated in cancers and other diseases, Xiao said. One microRNA can regulate hundreds of genes, she said.
The scientists compared microRNA levels in saliva to those in the blood and other body fluids, and found the levels of microRNA in blood and in saliva are very similar — indicating that a saliva sample would be a good measure of microRNAs in the body.
They also found that saliva contains another class of small RNAs, called piwi-interacting RNAs, or piRNAs, which are produced by stem cells, skin cells and germ cells. There are very few piRNAs in blood and most other body fluids, but Xiao’s analysis showed that piRNA are abundant in saliva. Although their function is not yet known, Xiao said they may protect the body from viral infection.
While most RNA molecules translate genetic code from DNA to make proteins, there is also a class called non-coding RNAs that does not.
“Saliva carries with it non-coding RNAs, microRNAs, piRNAs and circRNAs that are biomarkers for disease and health monitoring,” said Wong, who also is associate dean of research at the UCLA School of Dentistry. “Had we not done this collaboration, we would never know that non-coding RNAs, microRNAs, piRNAs and circRNAs exist in saliva.”
Their overriding conclusion is that saliva has tremendous medical and scientific value. In the not-too-distant future, dentists might be able to take saliva samples to analyze for a variety of diseases. And, Wong says, the research could lead to a new category of self-diagnostic devices. “This could indicate that wearable gear that informs you whether you have a disease — even before you have any symptoms — is almost here,” he said.
The Latest on: Molecular diagnostics
via Google News
The Latest on: Molecular diagnostics
- Crucial Need for Early Staging of Cancer Sets the Pace for Development of New Techniques in Breast Cancer Diagnostics Market: TMRon November 17, 2020 at 6:30 am
Stakeholders including medical companies are relentlessly working toward developing and unveiling breast diagnostic approaches that ...
- Worldwide Companion Diagnostic Industry to 2025 - Featuring Abbott Diagnostics, AccuraGen and Aethlon Medical Among Others - ResearchAndMarkets.comon November 17, 2020 at 5:31 am
The "Companion Diagnostic Markets - the Future of Diagnostics, by Funding Source and Application with Customized Forecasting/Analysis, COVID-19 Updates, and Executive and Consultant Guides 2021-2025" ...
- Co-Diagnostics Receives CE Markings For Logix Smart ABC, SARS-CoV-2 Gene Multiplex Testson November 17, 2020 at 3:53 am
(CODX) said Tuesday that its Logix Smart ABC (Influenza A/B, SARS-CoV-2) and its Logix Smart SARS-CoV-2 (genes RdRp/ ...
- Co-Diagnostics, Inc. Receives CE Markings for "ABC" and SARS-CoV-2 2-Gene Multiplex Testson November 17, 2020 at 2:30 am
PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of ...
- COVID-19 Impact Analysis on the Chinese Molecular Diagnostics Industryon November 16, 2020 at 8:16 pm
The "China Molecular Diagnostics Market, Volume, by Application [Oncology Testing (Breast Cancer, Colorectal Cancer, Prostate Cancer), Infectious Disease Testing (Virology, HPV), and Genetic Disease ...
- The Global POC Molecular Diagnostics Market is expected to grow by $ 1.31 bn during 2020-2024 progressing at a CAGR of 14% during the forecast periodon November 16, 2020 at 4:23 am
The analyst has been monitoring the POC molecular diagnostics market and it is poised to grow by $ 1. 31 bn during 2020-2024 progressing at a CAGR of 14% during the forecast period.New York, Nov.
- Africa Molecular Diagnostics Market – Detailed Analysis of Current Industry Figures with Forecasts Growth By 2026on November 12, 2020 at 10:52 pm
Selbyville, Delaware As per the report titled 'Africa Molecular Diagnostics Market Size By Technology, Application, Industry Analysis Report, Country Outlook, Application Potential, Competitive Market ...
- HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q3 2020 Results - Earnings Call Transcripton November 11, 2020 at 12:59 am
HTGM) Q3 2020 Results Earnings Conference Call November 10, 2020, 04:30 PM ET Company Participants Paul Arndt - LifeSci Advisors John Lubniewski - Chief Executive Officer Shaun McMeans – Chief ...
- HTG Molecular Diagnostics Reports Third Quarter 2020 Resultson November 10, 2020 at 1:30 pm
HTG Molecular Diagnostics, Inc., a life science company whose mission is to advance precision medicine, today reported its financial results for the quarter ended September 30, 2020.. HTG EdgeSeq ...
- HTG Molecular Diagnostics: Q3 Earnings Insightson November 10, 2020 at 12:29 pm
Shares of HTG Molecular Diagnostics (NASDAQ:HTGM) decreased 3.2% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose ...
via Bing News